UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:June 08,
Endonovo Therapeutics (PK) (USOTC:ENDV)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Endonovo Therapeutics (PK) Charts.
Endonovo Therapeutics (PK) (USOTC:ENDV)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Endonovo Therapeutics (PK) Charts.

Endonovo Therapeutics, Inc. News

Form 15-12G - Securities registration termination [Section 12(g)]
Saturday 3 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Thursday 4 January 2024 (4 months ago) • Edgar (US Regulatory)
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Saturday 30 December 2023 (4 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Tuesday 5 December 2023 (5 months ago) • Edgar (US Regulatory)
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
Thursday 16 November 2023 (6 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Thursday 12 October 2023 (7 months ago) • Edgar (US Regulatory)
Form 1-A/A - Offering Statement [Regulation A]: [Amend]
Friday 25 August 2023 (8 months ago) • Edgar (US Regulatory)
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 22 August 2023 (8 months ago) • Edgar (US Regulatory)

More Endonovo Therapeutics, Inc. News Articles